Docteur Renaud

Docteur Renaud is a French company specializing in high-quality skincare products that combine expert formulations with natural elements, catering to various skin concerns and emphasizing emotional well-being. Established in 1947 in France, Docteur Renaud focuses on skincare solutions. In September 2014, the company was acquired by Altercosmeto, a portfolio company of Phillimore and XAnge Private Equity, from Nuxe. The founder's history is not detailed in available data.

Docteur Renaud offers a diverse range of skincare products, including anti-aging creams, hydrating lotions, and specialized serums. Their notable offerings include the Global Anti-Aging line, Anti-Blemish treatments, and nourishing body oils infused with Monoi. Catering to both men and women, their products target various demographics within the beauty sector and are available in multiple international markets, focusing on professional skincare services through retailer and institutional partnerships. In the most recent fiscal year 2017, Docteur Renaud reported a revenue of USD 8,026,444.

20 with an EBITDA of USD 63,050. 60, supported by direct sales and retail partnerships, allowing a robust distribution model catering to both B2B and direct consumers. Following the acquisition by Altercosmeto in September 2014, Docteur Renaud aims to expand its product line and penetrate new markets. Specific new products and their release dates are currently not disclosed.

The company is strategizing to enhance its presence in international markets by targeting regions with growing demand for skincare products. The recent funding will facilitate these expansion plans and support new product development efforts.